Roswell Biotechnologies: Roswell Biotechnologies Slashes Workforce, Says Commercialization Roadmap Stays Unchanged
The company's CEO, Paul Mola, said the firm has faced difficulty raising its Series C financing round, which precipitated cuts "across the board" last month.
Read full article »
Roswell develops a molecular electronics sequencing platform for biomedical and industrial applications.
Read more